Currency: MYR
Period
Q3 FY2024 Earnings
--
76.91M
0.03
Strong Buy
Jul 16, 2024
Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
GENETEC: Consolidated results for the financial period ended 31/03/2024
May 28 05:22 ET
GENETEC: Consolidated results for the financial period ended 31/12/2023
Feb 27 04:09 ET
GENETEC: Consolidated results for the financial period ended 30/09/2023
Nov 28, 2023 05:05 ET
GENETEC: Quarterly rpt on consolidated results for the financial period ended 30/06/2023
Aug 29, 2023 05:10 ET
Read more
Updated: Jul 16, 2024
Buy
Hold
Underperform
Sell
No Data